Cardiology

We are delighted to announce the release of the latest EMJ Cardiology journal! Inside you will find a variety of content, including our…

This article explores an engaging debate from the ESC Congress 2025, which addresses the position of renal denervation (RDN)…

Inside, you will find a variety of content, including our in-depth review of the European Society of Cardiology (ESC) Congress 2025…

Smoking is a major risk factor for cardiovascular disease (CVD) and responsible for around 25% of all CVD-related deaths worldwide…

The emerging class of agents targeting factor XI/XIa offers the paradigm-shifting possibility of ‘haemostasis-sparing anticoagulation’…

In our latest issue of EMJ Cardiology you can explore a wide range of exclusive interviews with field experts, insightful peer-reviewed…

The AZALEA-TIMI 71 trial is the first study to provide definitive evidence that factor XI inhibition substantially reduces bleeding…

Explore a unique selection of peer-reviewed articles, exclusive interviews with leading experts, and a comprehensive review of the ESC Congress…